Ebola: Early immune response provides insight into vaccination

(German Center for Infection Research) The latest outbreaks of emerging pathogens, such as Ebola or Zika, emphasize the importance of the rapid development of vaccines. However, being able to predict the efficacy of new vaccines remains a challenge in vaccine development. DZIF scientists at the Heinrich Pette Institute and the University Medical Centre Hamburg-Eppendorf were successful in their study in assessing early on the longer-term immune response in humans after being vaccinated with the newly developed Ebola vaccine rVSV-ZEBOV.